Agios Pharmaceuticals AGIO

$31.80 -0.68 (-2.09%)

Valuation

Market cap
1,939,121,000
Revenue TTM
$54,030,000
Net income TTM
$-412,780,000
PE ratio
0.00
Forward PE
—
Profit margin
-763.98%
Debt to equity
0.00

Trading

Volume
569,900
Avg volume
1,053,584
Day's range
$31.65 – $32.82
Shares out
59,702,000
Stochastic %K
11%
Beta
0.63
Analysts
Strong Sell
Price target
$45.00

Price

Company profile

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disea...

Show more

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 649 8600
Website
https://www.agios.com
Address
88 Sidney Street, Cambridge, United States

Latest news

Stocktwits

Stonky_Mcprofitface Oct 2, 3:25 PM
$AGIO Absolute dog.
0 replies
stu4 Oct 2, 11:35 AM
$AGIO Hahaha , @Merlintrader …gave up of the fools at AGIO Mere welfare executives, all bounced from their previous jobs Fouse from Celgene Goof ball Goff from Alexion Milanova from Alexion , hmmm, little strange Jones , let go Kashnan showed up milking the system Sarah G …well they needed someone after the brains , Clancy and Bowden left . A basket full of misfits , no science brains in any of them . Jonathan Bithers got the F out went to vertex , and is making money !!! Oh and the above listed, will all sell shares when they can , because they have no faith in themselves , even at 6 figure salaries , the greed is the reason to be here .
0 replies
Stonky_Mcprofitface Sep 25, 10:57 AM
$AGIO Don’t get it with this stock. Can’t hold a gain.
1 replies
stu4 Sep 24, 10:19 AM
$AGIO John Maraganore, walked from this company and Board !!!! That says something about this pathetic bunch of public money blood suckers
0 replies
stu4 Sep 24, 10:18 AM
$AGIO Still chasing an executive team of failures Fouse Goff Milanova Jones Guehens Your Merlin activities, saving Lancelot, won’t work here The FDA doesn’t give out fake approvals !!! @Merlintrader ….keep up the pump…has the check cleared ?
0 replies
Merlintrader Sep 23, 4:25 PM
Agios ($AGIO): Mitapivat Q2 Revenue More Than Doubles, Sickle Cell PDUFA November 1 Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/agios-pharmaceuticals-stock-hub/
0 replies
stu4 Sep 21, 7:52 PM
$AGIO Pound the tables more Bank of America You have been since Greg Harrison called $60 and never hit it. It went to $16.95 with the same pathetic person , still grabbing a pay check Jackie Fouse ….the poison still breaths at the cesspool . Pound it harder , for the buffoons at AGIOS are known to fcuk up, and disappoint !!! Greg Harrison is now hiding out in another BOA arm , lol , selling different siht in another brown bag
0 replies
stu4 Sep 20, 8:55 PM
$AGIO maybe you too, are forging a fake narrative of AGIO , TO SAVE , FOUSE AND GOFF FROM HUMILIATION AS CEO FAILURES. AFTERALL, MERLIN GAVE LANCELOT THE SAME FAKE BADGE, TO MAKE HIM A KNIGHT ..@Merlintrader
0 replies